Cargando…
Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248088/ https://www.ncbi.nlm.nih.gov/pubmed/36661331 http://dx.doi.org/10.1182/bloodadvances.2022009469 |
| _version_ | 1785055296127762432 |
|---|---|
| author | Gribben, John Palomba, M. Lia Patel, Anik R. Nahas, Myrna Neelapu, Sattva S. |
| author_facet | Gribben, John Palomba, M. Lia Patel, Anik R. Nahas, Myrna Neelapu, Sattva S. |
| author_sort | Gribben, John |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10248088 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102480882023-06-09 Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma Gribben, John Palomba, M. Lia Patel, Anik R. Nahas, Myrna Neelapu, Sattva S. Blood Adv Commentary The American Society of Hematology 2023-01-24 /pmc/articles/PMC10248088/ /pubmed/36661331 http://dx.doi.org/10.1182/bloodadvances.2022009469 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Commentary Gribben, John Palomba, M. Lia Patel, Anik R. Nahas, Myrna Neelapu, Sattva S. Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma |
| title | Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma |
| title_full | Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma |
| title_fullStr | Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma |
| title_full_unstemmed | Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma |
| title_short | Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma |
| title_sort | need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248088/ https://www.ncbi.nlm.nih.gov/pubmed/36661331 http://dx.doi.org/10.1182/bloodadvances.2022009469 |
| work_keys_str_mv | AT gribbenjohn needforriskadjustmentincomparativeeffectivenessandcosteffectivenessstudiesinrrfollicularlymphoma AT palombamlia needforriskadjustmentincomparativeeffectivenessandcosteffectivenessstudiesinrrfollicularlymphoma AT patelanikr needforriskadjustmentincomparativeeffectivenessandcosteffectivenessstudiesinrrfollicularlymphoma AT nahasmyrna needforriskadjustmentincomparativeeffectivenessandcosteffectivenessstudiesinrrfollicularlymphoma AT neelapusattvas needforriskadjustmentincomparativeeffectivenessandcosteffectivenessstudiesinrrfollicularlymphoma |